Servicio de Neurología/Unidad de Neuroinmunología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
Neurologia. 2013 Jul-Aug;28(6):375-8. doi: 10.1016/j.nrl.2013.01.009. Epub 2013 May 3.
Treatments for multiple sclerosis therapy are rapidly evolving. It is believed that new drugs will be approved in the near future, thereby changing current indications for treatment. In this context, the Spanish Society of Neurology's study group on demyelinating diseases, which evaluates medication use in MS, has decided to draw up a consensus statement on the current indications and guidelines for multiple sclerosis treatment.
多发性硬化症的治疗方法正在迅速发展。据信，新的药物将在不久的将来获得批准，从而改变目前的治疗适应症。在此背景下，评估多发性硬化症药物使用情况的西班牙神经病学学会脱髓鞘疾病研究小组决定就多发性硬化症治疗的当前适应症和指南制定一份共识声明。
